Acne 

Actinic Keratosis 

Aesthetics

Alopecia

Biologic Treatments for Moderate to Severe Atopic Dermatitis 

Atopic Dermatitis 

COVID-19

Chronic Hand Eczema

Drug Watch

Eczema

General Dermatology 

Hidradenitis Suppurativa

Melasma

NP and PA

Pediatric Dermatology

Pigmentary Disorders 

Practice Management 

Precision Medicine and Biologics

Prurigo Nodularis

Emerging Therapies Plaque Psoriasis

Treatments for Plaque Psoriasis 

Psoriasis 

Psoriatic Arthritis 

Rare Disease

Rosacea 

Skin Cancer (Nonmelanoma)

Skin Cancer

Vitiligo

Wound Care

News

Media

Around the Practice

Between The Lines

Case-Based Peer Perspective

Clinical Case Collective

DermView

Expert Perspectives

Fellows Face Off

Frontline Forum

Medical World News

Patient Perspectives

Podcasts

Readout360

Recognize and Refer

Conferences

Conference Coverage

Conference Listing

Events

Case-Based Roundtable

Publication

Dermatology Times

CME/CE

Resources

DermIQ

Interactive Tools

Job Board

Partner Perspectives

Polls

Editorial Advisory Board

Partners

Subscribe

Marie Bosslett is the assistant editor of 

 and joined the MJH Life Sciences team in October 2024. She attended Loyola University in Baltimore, Maryland, and earned a Bachelor of Arts in Communication with minors in marketing and writing. When she’s not writing, Marie enjoys going to concerts, reading on the beach, and spending time with friends and family.

Articles

A 12-week regimen showed significant reductions in wrinkle severity and pigment improvement.

Adapinoid Shows Greater Efficacy and Tolerability Compared to Retinol

and joined the MJH Life Sciences team in February 2023. She attended Kent State University and earned a Bachelor of Science degree in journalism with minors in public relations and creative writing. She enjoys making and listening to music, reading, and spending time with her cats, Astrid and Marceline.

RAD will join MJH's multichannel model, enhancing its educational impact in atopic dermatitis, alopecia areata, vitiligo, and eczema.

Dermatology Times' Parent Company, MJH Life Sciences, Acquires Revolutionizing Atopic Dermatitis (RAD) Conference

Abeona's pz-cel has been granted a April 29, 2025, PDUFA date.

FDA Sets PFUDA Date, Accepts BLA Submission for Pz-cel in Epidermolysis Bullosa

Maddi Hebebrand is an associate editor of 

and joined the MJH Life Sciences team in May 2024. She attended Baldwin Wallace University, studying Media Production and Film, and is now finishing her Masters in Digital Media through Ohio University. When she's not writing, Maddi loves to read, attend concerts and spend time with her family.

Murase discussed safe dermatologic treatments during lactation, especially for chronic conditions needing biologics.

Jenny Murase, MD: Providing Dermatologic Support in Postpartum Care

About

Advertise

Contact Us

Do Not Sell My Information

Terms and Conditions

Privacy Policy

Dermatology Times and Multimedia Medical, LLC

Facebook

Linkedin

Topics

Acne

Pigmentary Disorders

Practice Management

Psoriasis

Psoriatic Arthritis

Rosacea

1rem

View

Comprehensive Case Studies in Plaque Psoriasis: Personalized Management Strategies for Diverse Patients

Case 1: A new Mom Looking for a PsO Treatment That Fits Into Her Lifestyle

Videos

Michael Lewitt, MD, discusses personalized management strategiesfor plaque psoriasis (PsO) through comprehensive case studies, highlighting treatment approaches for diverse patients, including a new mother seeking needle-free options, a 55-year-old man with psoriatic arthritis (PsA) and PsO, and a 7-year-old child with a recent PsO diagnosis, emphasizing the importance of tailored therapies based on each patient’s lifestyle, age, and specific needs.

Michael Lewitt, MD, provides an overview of Case-Based Roundtable and introduces a case involving a patient with a 10-year history of plaque psoriasis (PsO) in sensitive areas, discussing the significant impact on quality of life, the patient’s aversion to needles as a new mom, and the exploration of biologic therapies as a treatment option.

Michael Lewitt, MD, discusses a case involving a 55-year-old man with psoriasis (PsO) and psoriatic arthritis (PsA), highlighting challenges such as treatment for sensitive areas like the palms, soles, and scalp, mild morning stiffness, and the patient’s dissatisfaction with prior topical treatments; the discussion includes systemic and topical steroid use, concerns about TNF inhibitors, the effectiveness of phototherapy on limited areas, and the potential adverse events associated with the apremilast standard dose regimen, with phototherapy considered as a rescue option for flares.

Case 2: A 55-Year-Old Man With PsO and PsA

Michael Lewitt, MD, discusses a case involving a 7-year-old girl with plaque psoriasis (PsO) affecting body surface area (BSA) and the face, emphasizing the limited pediatric treatment options and the psychological and social impact on the child; the family initially opted for topical treatments like roflumilast, but preferred a more proactive approach, transitioning to apremilast while addressing concerns about gastrointestinal adverse events and the patient’s aversion to needles.

A 7-Year-Old Girl With a Recent PsO Diagnosis 

Case Based Peer Perspectives

I'm sorry, it seems there is no article provided for me to summarize and extract key takeaways from. Could you please provide the text of the article

Case 1: A new Mom Looking for a PsO Treatment That Fits Into Her Lifestyle

EP: 1.Case 1: A new Mom Looking for a PsO Treatment That Fits Into Her Lifestyle

EP: 2.Case 2: A 55-Year-Old Man With PsO and PsA

EP: 3.A 7-Year-Old Girl With a Recent PsO Diagnosis